Embrace clarity and precision in your healthcare journey with the IHC AE1/AE3 Test, a specialised diagnostic procedure available in Hyderabad at Sprint Diagnostics that unveils the secrets of your tissue samples. This advanced technique utilises specific antibodies, AE1 and AE3, to meticulously identify and analyse cytokeratins, proteins that play a pivotal role in the structural integrity of epithelial cells.
Gain Unparalleled Insights into Tissue Health
Leveraging the power of immunohistochemistry (IHC), the IHC AE1/AE3 Test delves deep into the microscopic world, providing a detailed map of cytokeratin distribution within your tissue sample. This valuable information proves invaluable in diagnosing and characterising a wide range of diseases, particularly cancers of epithelial origin such as carcinomas.
Empowering Informed Treatment Decisions
By illuminating the presence and distribution of cytokeratins, the IHC AE1/AE3 Test empowers healthcare professionals with critical insights, enabling them to make informed treatment decisions and optimise patient outcomes. This test plays a crucial role in guiding treatment strategies, preventing future complications, and promoting overall well-being.
Test NameIHC - AE1/AE3
Sample TypeTissue
Preparations RequiredNo specific preparation required for this test.
Report Time3 Days
Your Gateway to Comprehensive Tissue Analysis
If you're seeking comprehensive insights into your tissue samples, the IHC AE1/AE3 Test stands ready to provide you with the knowledge you need to make informed decisions about your health. This specialised diagnostic procedure is readily available in Hyderabad, offering you access to cutting-edge technology and expert interpretation of your results.
Embrace Precision Diagnostics for Optimal Care
Refrain from letting unanswered questions about your tissue samples cloud your health journey. Embrace the power of precision diagnostics with the IHC AE1/AE3 Test and gain the knowledge you need to make informed decisions about your well-being.
Schedule Your Appointment Today
Take charge of your health and schedule your IHC AE1/AE3 test today. Sprint Diagnostics' team of experienced professionals is dedicated to providing you with quality care and ensuring that you receive the information you need to make informed decisions about your health.
Home Sample Collection Process
1
Book your convenient slot
2
Sample Collection by Phlebotomist
3
Reporting of the sample at lab
4
Download Reports
Frequently Asked Questions
A tissue sample, usually obtained through a biopsy, is used for this test.
No specific preparation is necessary for this test.
The results are typically available within 5-7 days, although this can vary depending on the lab.
The risks associated with this test are primarily linked to the biopsy procedure used to obtain the
tissue sample. These may include infection, bleeding, and discomfort at the site of the biopsy.
A positive result indicates the presence of cytokeratins in the tissue sample. This is a common finding
in carcinomas, a type of cancer that begins in the epithelial cells.
A negative result indicates that no cytokeratins were detected in the tissue sample. This result may rule
out certain diseases, but further testing may be needed for a definitive diagnosis.
The results of this test can be affected by several factors, including the quality of the tissue sample
and any treatments or medications the patient is currently receiving.
Yes, this test can be used to monitor the response to treatment in certain cases, as a decrease in
cytokeratin levels may indicate that the treatment is working.
If your results are abnormal, it's important to discuss them with your doctor. They can help interpret
the results and guide you on the next steps, which may include further testing or treatment options.
Yes, this test can be performed on patients of all ages, including children, if indicated by their
medical condition.
Yes, this test can be performed during pregnancy if medically necessary. However, any potential risks to
the mother and fetus should be considered.
